Sarepta Therapeutics (SRPT) Operating Margin Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 31,483.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,483.00 |
| Dec 31, 2025 | -11,748.00 |
| Sep 30, 2025 | -3,064.00 |
| Jun 30, 2025 | 1,911.00 |
| Mar 31, 2025 | -23,373.00 |
| Dec 31, 2024 | 1,924.00 |
| Sep 30, 2024 | 1,103.00 |
| Jun 30, 2024 | 59,989.00 |
| Mar 31, 2024 | 6,291.00 |
| Dec 31, 2023 | 6,846.00 |
| Sep 30, 2023 | 5,694.00 |
| Jun 30, 2023 | -50,012.00 |
| Mar 31, 2023 | 34,035.00 |
| Dec 31, 2022 | 3,135.00 |
| Sep 30, 2022 | -4,503.00 |
| Jun 30, 2022 | 1,818.00 |
| Mar 31, 2022 | -29,147.00 |
| Dec 31, 2021 | 66,444.00 |
| Sep 30, 2021 | 59,113.00 |
| Jun 30, 2021 | 41,359.00 |
| Mar 31, 2021 | 78,902.00 |
| Dec 31, 2020 | -52,898.00 |
| Sep 30, 2020 | -48,454.00 |
| Jun 30, 2020 | -24,086.00 |
| Mar 31, 2020 | -80,459.00 |
| Dec 31, 2019 | -6,487.00 |
| Sep 30, 2019 | -3,547.00 |
| Jun 30, 2019 | -15,022.00 |
| Mar 31, 2019 | -4,021.00 |
| Dec 31, 2018 | -12,468.00 |
| Sep 30, 2018 | 1,058.00 |
| Jun 30, 2018 | 4,025.00 |
| Mar 31, 2018 | 19,257.00 |
| Dec 31, 2014 | -16.44 Mn |
| Sep 30, 2014 | -258,169.00 |
| Jun 30, 2014 | -59,291.00 |
| Mar 31, 2014 | -6,809.00 |
| Dec 31, 2013 | -110,961.00 |
| Sep 30, 2013 | -50,703.00 |
| Jun 30, 2013 | -52,944.00 |
| Mar 31, 2013 | -28,324.00 |